Jeffrey D Chulay

Summary

Publications

  1. pmc Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method
    Jeffrey D Chulay
    Applied Genetic Technologies Corporation, 11801 Research Drive, Alachua, FL 32615, USA
    Hum Gene Ther 22:155-65. 2011
  2. doi request reprint Herpes simplex virus clearance during purification of a recombinant adeno-associated virus serotype 1 vector
    Guo jie Ye
    Applied Genetic Technologies Corporation, Alachua, FL 32615
    Hum Gene Ther Clin Dev 25:212-7. 2014

Collaborators

Detail Information

Publications2

  1. pmc Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method
    Jeffrey D Chulay
    Applied Genetic Technologies Corporation, 11801 Research Drive, Alachua, FL 32615, USA
    Hum Gene Ther 22:155-65. 2011
    ..These results support continued development of rAAV-CB-hAAT for treatment of AAT deficiency...
  2. doi request reprint Herpes simplex virus clearance during purification of a recombinant adeno-associated virus serotype 1 vector
    Guo jie Ye
    Applied Genetic Technologies Corporation, Alachua, FL 32615
    Hum Gene Ther Clin Dev 25:212-7. 2014
    ..35 ml each, which would contain a maximum of 3.27×10(-3) pfu of HSV. These results support the safety of rAAV vectors produced using our rHSV complementation method. ..